Anthropic ~$30B funding at ~$380B val + Coefficient Bio acquisition

Closed ~$30B round ($380B val); $400M all-stock Coefficient Bio (AI biotech drug discovery, <10 engineers, Genentech alums); $30B ARR rev exploding 1420% YoY; $2B chasing secondaries; Broadcom expanded 3.5GW compute deal ($21-42B rev pot). Biotech diversification amid OpenAI rivalry; enterprise edge; IPO spec; part of Q1 concentration.